Star Health Insurance partners with Medi Assist to transform claims process using AI and digital innovation
Shares of Star Health and Allied Insurance may remain in focus on Wednesday, June 25, after the company announced a strategic partnership with Medi Assist to enhance its claims management system through artificial intelligence (AI) and digital tools.
In an exchange filing, Star Health said the collaboration will enable the adoption of MAtrix, an AI-powered claims platform developed by Medi Assist. The move is aimed at delivering faster settlements, reducing fraud, and improving customer engagement.
Star Health's Managing Director and CEO Anand Roy said the partnership is a milestone in the company's journey towards building a more agile and technology-driven claims ecosystem. 'Claims are at the heart of the insurance experience, and with Medi Assist's platform, we are enhancing speed, accuracy, and consistency, while focusing on fraud prevention,' he added.
The new platform introduces intelligent automation, reduces manual intervention, and streamlines workflows. It also enables AI-powered chatbots, virtual assistants, and omnichannel support, including integration with WhatsApp and mobile apps.
Additionally, Star Health said the partnership will allow real-time data exchange with stakeholders like hospitals and the National Health Claims Exchange (NHCX) through a unified API architecture.
Medi Assist CEO Satish Gidugu said the partnership will set new industry standards for technology-driven insurance operations.
Star Health closed FY25 with a gross written premium of Rs 17,553 crore and a net worth of Rs 8,668 crore. The company currently operates over 913 offices and has partnerships with more than 14,000 network hospitals.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
29 minutes ago
- Business Upturn
Texmaco Rail shares rally 8% on major export order from CAMALCO SA, Cameroon
Texmaco Rail & Engineering shares surged 8% in morning trade on June 26 after the company announced a significant international order win from CAMALCO SA, Cameroon. As of 9:15 AM, the shares were trading 6.81% higher at Rs 185.19. The company received a Letter of Intent dated June 24, 2025, for a contract worth USD 62.24 million (approx. ₹535 crore). The deal includes manufacturing and supplying 560 open-top wagons valued at USD 32.76 million (₹282 crore), along with a 20-year maintenance contract worth USD 29.48 million (₹253 crore). The wagons will be delivered in two phases over 24 months from the purchase order date. Additionally, the contract includes the potential for an extra 1,040 wagons to be supplied over the next five years, along with extended maintenance support. This deal marks a major milestone in Texmaco's global expansion strategy and highlights the company's growing presence in international markets. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
29 minutes ago
- Business Upturn
KNR Constructions jumps 16% in 2 days on Rs 4,800 crore NTPC coal block order win
By Aditya Bhagchandani Published on June 26, 2025, 09:24 IST Shares of KNR Constructions surged 16% over the past two sessions after the company announced a major order win worth Rs 4,800 crore from Patratu Vidyut Utpadan Nigam, a subsidiary of NTPC. The contract pertains to the development and operation of the Banhardih coal mining block located in Jharkhand. On Thursday, June 26, KNR Constructions' stock rose nearly 5% to ₹242.09 on the NSE. This follows an 11% jump in Wednesday's trade, when the stock hit an intraday high of ₹235.85. The company's market capitalization now stands at Rs 6,716 crore. The Rs 4,800 crore project will be executed by a joint venture between KNR Constructions and Harsha Constructions, where KNR will operate 74% of the mining block. The project timeline includes an initial development period of 360 days followed by a five-year operational phase. The coal block holds reserves of approximately 34.50 million tonnes. The stock momentum comes despite KNR reporting a 61% decline in net profit to Rs 248 crore for the March quarter. Analysts suggest that the large order provides visibility for future revenue and earnings recovery. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
29 minutes ago
- Business Upturn
SMS Pharmaceuticals share jump 6% after its Hyderabad facility clears USFDA inspection with zero observations
By Aman Shukla Published on June 26, 2025, 09:24 IST Shares of SMS Pharmaceuticals surged 6% in early trade after the company announced the successful completion of a USFDA inspection at its Central Laboratory Analytical Services in Gagillapur, Hyderabad. As of 9:23 AM, the shares were trading 5.77% higher at Rs 252.90. The inspection, conducted between June 23 and June 25, 2025, concluded with zero Form 483 observations — a clear indicator of full compliance with USFDA norms. This is the second successful USFDA audit at the lab, underlining the company's robust quality assurance systems and regulatory preparedness. The Central Lab operates as an independent analytical testing facility, serving as a key quality control hub for the company. The clean report from the USFDA reinforces SMS Pharma's strong adherence to Current Good Manufacturing Practices (CGMP) and Good Laboratory Practices (GLP) across its operations. This development boosts investor confidence, as regulatory compliance plays a crucial role in pharmaceutical exports to the US — one of SMS Pharma's key markets. It also strengthens the company's reputation as a trusted global pharmaceutical player, with a sharp focus on quality, safety, and transparency. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
